Scientific Sessions
Scientific Sessions
  • Program
  • #AHA24
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
  • Journeys
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
  • Journeys
Resources
  • Program
  • #AHA24
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon Facebook iconInstagram iconYouTube iconPinterest iconLinkedIn icon
Oct 25th, 2023

Today's Opening Session and Main Events

Leading-edge presentations from the late-breaking science report on semaglutide to cardiac arrest on the athletic field highlight Saturday's science.


Main Event presentation

Opening Session

Saturday, Nov. 11 | 8-9:15 a.m.
Main Event 1
Welcome
Joseph C. Wu, MD, PhD, FAHA
Chair Opening Remarks
Amit Khera, MSc, FACC, FAHA, FASPC
Awards Presentation
Joseph C. Wu, MD, PhD, FAHA
Distinguished Scientist Recognition
Patrick T. Ellinor, MD, PhD, FAHA
Carlos M. Ferrario, MD, FAHA
Judith S. Hochman, MD, FAHA
Deepak Srivastava, MD, FAHA
Jeffrey I. Weitz, MD, FAHA
Cornelia M. Weyand, MD, PhD, FAHA
Joseph A. Vita Award
Pradeep Natarajan, MD, MMSc
Nanette K. Wenger Award
Zainab Mahmoud, MD, MSc
Late-Breaking Science Session
LBS.01 | Obesity—Novel Therapeutics and Implications for Population Health

Saturday’s Main Events

Annual Dr. Nanette K. Wenger Research Goes Red® Award for Best Scientific Article on Cardiovascular Disease and Stroke in Women
9:45-11 a.m. | 114/Nutter Theater
Zainab Mahmoud, MD, MSc
Racial Disparities in Specific Cardiovascular Outcomes

Valve-tastic! What’s the Latest and Greatest in Lifetime Management, Imaging, Science and Technology in Valvular Heart Disease
9:45-11 a.m. | Main Event II
This session will give a high-level overview for cutting-edge developments in valvular heart disease examining lifetime management of aortic valve disease, multimodality management of mitral valve disease, new imaging insights, what’s hot in basic and translational science, and what’s next in technology and clinical trials.

Eliminating Health Inequity in Cardiovascular Disease
1:30-2:45 p.m. | Main Event II
There have been long-standing and persistent racial and ethnic disparities in cardiovascular disease and stroke mortality. Globally, the largest decrease in life expectancy during the COVID-19 pandemic was observed in the U.S., with Blacks and Hispanics having the greatest decrease. Since the 1980s, there has also been widening disparities in cardiovascular disease mortality, stroke mortality and maternal mortality in rural counties versus urban counties. This main event session will focus on the medical community’s role in moving health equity and social justice forward, research innovations and data-driven interventions to eliminate health disparities, diversifying the health care workforce, improving both urban and rural health and funding priorities.

Distinguished Scientist Lecture Session
3:15-4:30 p.m. | 114/Nutter Theater 
Elizabeth M. McNally, MD, PhD, FAHA | Cardiovascular Genetics From Diagnosis to Therapy 

Cardiac Arrest on the Athletic Field: A Team Approach
3:15-4:30 p.m. | Main Event II 
This session will focus on cardiac arrest on the athletic field, addressing various aspects such as common and uncommon causes, emergency preparedness, athletic screening and return to play following such an event. The session will also explore the differentiation between athlete heart and cardiomyopathy as well as the role of myocardial inflammation on SCD during athletic participation. The highlight of the session will include athletes who survived SCD on the field to provide their perspectives on life after death and experiences with attempting to return to sports.

Interesting Stories
Screening for Kidney Disease to Reduce CVD Risk
Sponsored by Bayer
Screening for Kidney Disease to Reduce CVD Risk
Unmet Needs in Hypertension Toolkit
Sponsored by Medtronic
Unmet Needs in Hypertension Toolkit
Lp(a) and Peripheral Artery Disease Toolkit
Sponsored by Kaneka Corporation
Lp(a) and Peripheral Artery Disease Toolkit
CME Gameshow Style Sympo: Navigating New Paradigms in Thrombosis Management
Sponsored by Medscape
CME Gameshow Style Sympo: Navigating New Paradigms in Thrombosis Management
More Content
Maxresdefault 65561fbdb9acc
AHA23
Watch: Scientific Sessions 2023 Day 2 | Sunday, Nov. 12
Nov 16th, 2023
Panel of speakers
AHA23
Getting to the Heart of Stroke™
Nov 15th, 2023
Hqdefault 6554fd1be4044
AHA23
Watch: Scientific Sessions 2023 | Day 1, Saturday, Nov. 11
Nov 15th, 2023
Maxresdefault 6554fad25bb7c
AHA23
Watch: Scientific Sessions 2023 Pre-Sessions Symposia & Early Career Day
Nov 15th, 2023
Audience shot
AHA23
Late-breaking science| Achieving equity in prevention
Nov 15th, 2023
audience shot
AHA23
Novel mechanisms for lipid-lowering therapy
Nov 14th, 2023
LBS 08 panelists
AHA23
Late-breaking science: AI at the bedside
Nov 14th, 2023
Lbs05 Panel Web
AHA23
Shocking decisions in AFib care
Nov 13th, 2023
Lbs04 Panel2 Web
AHA23
Drugs, diet and delivery can optimize hypertension outcomes
Nov 13th, 2023
Jane E. Freedman, MD, Ann Marie Schmidt, MD, M. Benjamin Shoemaker, MD, MSCI, J. Kevin Donahue, MD
AHA23
Established lecture to present new research developments
Nov 13th, 2023
Randi Foraker, PhD, MA, FAHA, FAMIA, Jessica L. Mega, MD, MPH
AHA23
Artificial intelligence shows promise and pitfalls
Nov 13th, 2023
Clyde W. Yancy, MD, MSc, MACC, FAHA, and Reinier Boon, PhD
AHA23
Age: Is it a number, or a biology?
Nov 13th, 2023